Hyundai Pharmaceutical Co., Ltd. (KOSE: A004310)
Health Care · Pharmaceuticals · KR
₩5,850.00
-7.29% today · +47.5% 1Y
Hyundai Pharmaceutical Co., Ltd. (KOSE: A004310) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $116.83M.
Over the last twelve months the share price has gained 47.5%, trading between 3.50K and 15.96K.
Tweenvest scores Hyundai Pharmaceutical Co., Ltd. across four factors: quality 62/100, value 7/100, dividend 45/100. Its strongest factor is quality.
A004310 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $116.83M
- Revenue (TTM)
- $102.19M
- P/E
- 96.95
- EPS
- 60.34
- Dividend yield
- 0.51%
- Beta (5Y)
- 0.70
- 52-week high
- ₩15,960.00
- 52-week low
- ₩3,500.00
- Avg volume (3M)
- —
- Shares outstanding
- 27.68M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,256.00 | +0.05% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.16 | +0.34% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.25 | -0.20% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.30 | -1.41% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.00 | -1.14% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.13 | +0.21% |
Figures last refreshed Aug 18, 2026.